akandacorp.com - AKAN Company Value to Revenue Ratio

akandacorp.com (AKAN) - corporate logo

Akanda is developing its biotechnological potential through R&D in the medical cannabis sector. The EV-to-sales ratio visualizes the tension between risk discounting and growth expectations, where 38757.58 represents the current metric. The company's revenues depend on regulatory cycles and global liberalization, although oversupply and slow legalization in the US are weakening the business's defensive barriers.

AKAN Akanda Corporation EV/Sales Multiple (11/23/2025 - 11/20/2026)

Akanda Corp - analytical breakdowns and key metrics (AKAN)

- share price and consensus valuation forecast:
Initial company analysis:akandacorp.com, AKAN
Mass-produced product of Akanda Corp.

This indicator determines the market value of the business minus net debt relative to annual revenue, eliminating the impact of debt load on the valuation. By analyzing the EV/Sales ratio, an investor assesses the monetization efficiency of Akanda (AKAN) assets, where the implementation of energy-saving technologies and sustainable farming directly impacts operating profitability and the long-term attractiveness of the company's valuation.